Albert David Profit & Loss Annual

BSE: 524075 | NSE: ALBERTDAVD | ISIN: INE155C01010 | Sector: Biotechnology & Drugs

1,278.00 +11.90 (0.94%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	362.46	341.56	313.51	247.45
Total Revenue	362.46	341.56	313.51	247.45
Costof Revenue Total	126.40	143.60	130.13	96.71
Gross Profit	236.06	197.96	183.38	150.74
Selling/ General/ Admin Expenses Total	88.43	94.79	97.76	93.36
Depreciation/ Amortization	6.83	8.55	8.81	8.23
Other Operating Expenses Total	100.75	56.48	43.22	36.71
Total Operating Expense	322.41	305.32	281.52	236.50
Operating Income	40.05	36.24	31.99	10.95
Interest Inc( Exp) Net- Non- Op Total	-3.21	68.74	121.20	157.19
Other Net	57.55	7.60	0.84	0.73
Net Income Before Taxes	97.29	50.74	47.30	27.44
Provisionfor Income Taxes	21.87	14.56	12.04	5.30
Net Income After Taxes	75.42	36.17	35.26	22.14
Net Income Before Extra Items	75.42	36.17	35.26	22.14
Net Income	75.42	36.17	35.26	22.14
Income Availableto Com Excl Extra Ord	75.42	36.17	35.26	22.14
Income Availableto Com Incl Extra Ord	75.42	36.17	35.26	22.14
Diluted Net Income	75.42	36.17	35.26	22.14
Diluted Weighted Average Shares	0.57	0.57	0.57	0.57
Diluted EPS Excluding Extra Ord Items	132.15	63.39	61.78	38.80
DPS- Common Stock Primary Issue	11.50	9.00	9.00	6.00
Diluted Normalized EPS	132.15	63.36	58.71	38.69
Research Development	-	18.96	16.01	15.26
Gain( Loss)on Saleof Assets	-	0.21	23.49	0.38
Unusual Expense( Income)	-	-	0.00	-0.04